Role of Green Chemistry in Antipsychotics' Electrochemical Investigations Using a Nontoxic Modified Sensor in McIlvaine Buffer Solution

A new low-cost green electrochemical sensor based on nontoxic polyethylene glycol (PEG) and silver nanoparticles was used to improve the sensitivity of the carbon paste electrode for the investigation of olanzapine (OLZ) in dosage arrangements and in the existence of its coadministered drug fluoxetine and in the drug formulation. Scanning electron microscopy measurements were carried out to emphasize the morphology of the electrode surface. Cyclic voltammetry and differential pulse voltammetry were used to explore the diffusion and linearity behaviors of OLZ. Impedance spectroscopy measurements were determined to investigate the ac behavior of OLZ and then an ideal electrical circuit was modeled. A linear calibration was obtained from 1.0 × 10^-8 to 1.25 × 10^-4 M. The limit of detection was 1.5 × 10^-9 M, whereas the limit of quantification was 5 × 10^-9 M. The way has been wholly authenticated concerning linearity, precision, accuracy, reproducibility, sensitivity, and selectivity.

A novel electrochemical analysis of the legal psychoactive drug caffeine using a zeolite/MWCNT modified carbon paste sensor

Caffeine (Caf) is a natural central nervous system stimulant categorized by the US Food and Drug Administration as a safe drug and its maximal amount in soft drinks has been approximately determined to be lower than 200 mg L⁻¹.

The application of a bee glue-modified sensor in daclatasvir dual effect detection

A simple and novel carbon paste sensor containing chemically mixed propolis (bee glue) and graphene oxide (GO) was prepared, then electrochemical deposition of silver nanoparticles (AgNPs) was performed to fabricate a selective and sensible electrochemical sensor to detect Daclatasvir (DAC).

Correction: A novel methionine/palladium nanoparticle modified carbon paste electrode for simultaneous determination of three antiparkinson drugs

Correction for ‘A novel methionine/palladium nanoparticle modified carbon paste electrode for simultaneous determination of three antiparkinson drugs’ by Nahla N. Salama et al., RSC Adv., 2015, 5, 14187–14195.

A novel surfactant silica gel modified carbon paste electrode in micellar media for selective determination of diminazene aceturate in the presence of its stabilizer

A novel irreversible anodic voltammetric method was introduced for selective determination of diminazene aceturate in the presence of phenazone as a stabilizer.

A novel methionine/palladium nanoparticle modified carbon paste electrode for simultaneous determination of three antiparkinson drugs

A simple and novel method for the simultaneous determination of entacapone (EN), levodopa (LD) and carbidopa (CD) based on a methionine/palladium nanoparticle modified carbon paste electrode is described.

Determination of morphine at gold nanoparticles/Nafion® carbon paste modified sensor electrode

A novel and effective electrochemical sensor for the determination of morphine (MO) in 0.04 mol L(-1) universal buffer solution (pH 7.4) is introduced using gold nanoparticles electrodeposited on a Nafion modified carbon paste electrode. The effect of various experimental parameters including pH, scan rate and accumulation time on the voltammetric response of MO was investigated. At the optimum conditions, the concentration of MO was determined using differential pulse voltammetry (DPV) in a linear range of 2.0 × 10(-7) to 2.6 × 10(-4) mol L(-1) with a correlation coefficient of 0.999, and a detection limit of 13.3 × 10(-10) mol L(-1), respectively. The effect of common interferences on the current response of morphine namely ascorbic acid (AA) and uric acid (UA) is studied. The modified electrode can be used for the determination of MO spiked into urine samples, and excellent recovery results were obtained.

Treatment of childhood brucellosis: results of a prospective trial on 113 children

Treatment of childhood brucellosis is controversial and is currently dependent on inclusion of aminoglycoside antibiotics which are both costly and potentially toxic. Hence an alternate mode of therapy preferably dependent exclusively on oral agents is desirable because this decreases medical cost. In this study we prospectively treated 113 children with a combination of two oral agents, trimethoprim-sulfamethoxazole (10 to 12 mg/kg trimethoprim, 50 to 60 mg/kg sulfamethoxazole and rifampin 15 to 20 mg/kg in two divided doses for 6 weeks. The treatment was well-tolerated and all patients responded by defervescence of fever and resolution of all symptoms within 1 to 3 weeks. Relapse after 6 months occurred in four children all of whom responded to repeat therapy by the same agents. We conclude that the combination of trimethoprim-sulfamethoxazole and rifampin is both cost-effective and safe for the treatment of childhood brucellosis.